ssmuБюллетень сибирской медициныBulletin of Siberian Medicine1682-03631819-3684Siberian State Medical University, the Ministry of Healthcare of the Russian Federation10.20538/1682-0363-2009-1-64-70ssmu-1746Research ArticleНАУЧНЫЙ И УЧЕБНЫЙ ПРОЦЕСС: МЕТОДИЧЕСКИЙ СЕМИНАРSCIENTIFIC AND STUDYING PROCESS: METHODIC SEMINARРоль апоптоза в развитии аутоиммунных заболеваний щитовидной железыThe role of apoptosis in development of autoimmune thyroid diseasesНедосековаЮ. В.NedosekovaYu. V.

аспирант кафедры патофизиологии

УразоваО. И.UrasovaO. I.

д р мед наук профессор кафедры патофизиологии

КравецЕ. Б.KravetsYe. B.

д р мед наук профессор зав кафедрой эндокринологии и диабетологии

ЧайковскийА. В.ChaikovskyA. V.

студент VI курса педиатрического факультета

Сибирский государственный медицинский университетRussian Federation200928022009816470Copyright © Недосекова Ю.В., Уразова О.И., Кравец Е.Б., Чайковский А.В., 20092009Недосекова Ю.В., Уразова О.И., Кравец Е.Б., Чайковский А.В.Nedosekova Y.V., Urasova O.I., Kravets Y.B., Chaikovsky A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://bulletin.ssmu.ru/jour/article/view/1746

In the review representations about a role apoptosis by autoimmune thyroid diseases, such as Graves' disease and Hashimoto's thyroiditis, the basic pathogenetic links immunological abnormalities at the these diseases have been discussed. At has been demonstrated changes in a thyroid gland, and also changes endocellular pro- and anti-apoptotic factors are shown at Hashimoto's thyroiditis and Graves' disease.

апоптозболезнь Грейвсаболезнь ХасимотоapoptosisGraves' diseaseHashimoto's thyroiditisReferencesАбрамова Н.А., Фадеев В.В. и др. Консервативное лечение болезни Грейвса: принципы, маркеры рецидива и ремиссии//Проблемы эндокринологии. 2005. Т. 51. № 6. С. 44-49Абрамова Н.А., Фадеев В.В. и др. Консервативное лечение болезни Грейвса: принципы, маркеры рецидива и ремиссии//Проблемы эндокринологии. 2005. Т. 51. № 6. С. 44-49Белушкина Н.Н., Северин С.Е. Молекулярные основы патологии апоптоза//Арх. патологии. 2001. № 1. С. 51-60Белушкина Н.Н., Северин С.Е. Молекулярные основы патологии апоптоза//Арх. патологии. 2001. № 1. С. 51-60Кандрор В.И., Крайнова С.И., Крюкова И.В. и др. Антитиреоидные антитела и аутоиммунные заболевания//Проблемы эндокринологии. 1997. № 3. С. 25-30Кандрор В.И., Крайнова С.И., Крюкова И.В. и др. Антитиреоидные антитела и аутоиммунные заболевания//Проблемы эндокринологии. 1997. № 3. С. 25-30Крайнова С.И., Крюкова И.В., Мкртумова Н.А. и др. Стимуляция роста «нормальных» тиреоцитов лимфоцитами, инфильтрирующими ткань диффузного токсического зоба//Проблемы эндокринологии. 2001. № 3. С. 3-5.Крайнова С.И., Крюкова И.В., Мкртумова Н.А. и др. Стимуляция роста «нормальных» тиреоцитов лимфоцитами, инфильтрирующими ткань диффузного токсического зоба//Проблемы эндокринологии. 2001. № 3. С. 3-5.Пивень Н.В., Новиков В.В., Лухверчик Л.Н., Кузьменко-ва Е.И. Иммуноферментный анализ FAS-рецептора (CD95) у лиц с патологией щитовидной железы//Иммунопатология, аллергология, инфектология. 2001. № 3. С. 15-20Пивень Н.В., Новиков В.В., Лухверчик Л.Н., Кузьменко-ва Е.И. Иммуноферментный анализ FAS-рецептора (CD95) у лиц с патологией щитовидной железы//Иммунопатология, аллергология, инфектология. 2001. № 3. С. 15-20Самуилов В.Д., Алексин А.В., Лагунова Е.М. Программированная клеточная гибель//Биохимия. 2000. Т. 65. № 8. С. 1029-1046Самуилов В.Д., Алексин А.В., Лагунова Е.М. Программированная клеточная гибель//Биохимия. 2000. Т. 65. № 8. С. 1029-1046Ярилин А.А. Природа феномена и его роль в целостном организме//Патолог. физиология. 1998. № 2. С. 38-48Ярилин А.А. Природа феномена и его роль в целостном организме//Патолог. физиология. 1998. № 2. С. 38-48Ярилин А.А. Апоптоз и его место в иммунных процессах//Иммунология. 1996. № 6. С. 10-22Ярилин А.А. Апоптоз и его место в иммунных процессах//Иммунология. 1996. № 6. С. 10-22Aravid L., Dixit V.M., Koom E.V. The domains of death: evolution of the apoptosis machinery//Trends Biochem. Sci. 1999. V. 24. P. 47-53Aravid L., Dixit V.M., Koom E.V. The domains of death: evolution of the apoptosis machinery//Trends Biochem. Sci. 1999. V. 24. P. 47-53Arends M.J., Wyllie A.H. Mechanism and role in patology//Inlern. Rev. Exp. Pathol. 1991. V. 32. P. 223-254Arends M.J., Wyllie A.H. Mechanism and role in patology//Inlern. Rev. Exp. Pathol. 1991. V. 32. P. 223-254Arscott P.L., Knapp J., Rymaszewski M., Bartron J.L. et al. Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor // Endocrinology. 1997. V. 138. P. 5019—5027.Arscott P.L., Knapp J., Rymaszewski M., Bartron J.L. et al. Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor // Endocrinology. 1997. V. 138. P. 5019—5027.Bellgrau D., Gold D., Selawry H. et al. A role for CD95 ligand in preventing graft rejection // Nature. 1995. V. 377. P. 630— 632.Bellgrau D., Gold D., Selawry H. et al. A role for CD95 ligand in preventing graft rejection // Nature. 1995. V. 377. P. 630— 632.Bennett M.R. Apoptosis in the cardiovascular system Heart // 2002. V. 87. 5. P. 480—487.Bennett M.R. Apoptosis in the cardiovascular system Heart // 2002. V. 87. 5. P. 480—487.Bermann M., Magee M., Koenig R.J. Differential autoantibody responses to thyroid peroxidase in patients with Grave’s desease and Hashimoto thyroiditis // J. of Clinical Endocrinology and Metabolism. 1993. V. 77. P. 1098—1101.Bermann M., Magee M., Koenig R.J. Differential autoantibody responses to thyroid peroxidase in patients with Grave’s desease and Hashimoto thyroiditis // J. of Clinical Endocrinology and Metabolism. 1993. V. 77. P. 1098—1101.Boice L.H., Minn A.J., June C.H. et al. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division // Proc. Natl. Acad. Sci. USA. 1995. V. 92. P. 1223—1232.Boice L.H., Minn A.J., June C.H. et al. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division // Proc. Natl. Acad. Sci. USA. 1995. V. 92. P. 1223—1232.Combadiere B., Reise Sousa C., Trageser C. et al. Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo // Immunity. 1998. V. 9. P. 305—313.Combadiere B., Reise Sousa C., Trageser C. et al. Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo // Immunity. 1998. V. 9. P. 305—313.De Flora A., Franco L., Guida L., Bruzzone S. et al. Ectocellular CD38-catalyzed synthesis and intracellular Ca2+-mobilizing activity of cyclic ADP-ribose // Cell Biochem. Biophys. 1998. V. 28. P. 45—62.De Flora A., Franco L., Guida L., Bruzzone S. et al. Ectocellular CD38-catalyzed synthesis and intracellular Ca2+-mobilizing activity of cyclic ADP-ribose // Cell Biochem. Biophys. 1998. V. 28. P. 45—62.De Maria R., Testi R. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity // Immunol. Today 1998. V. 19. P. 121—125.De Maria R., Testi R. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity // Immunol. Today 1998. V. 19. P. 121—125.Fry T.J., Connick E., Falloon J. et al. A potential role for interleukin-7 in T-cell homeostasis // Blood. 2001. V. 97. P. 2983— 2990.Fry T.J., Connick E., Falloon J. et al. A potential role for interleukin-7 in T-cell homeostasis // Blood. 2001. V. 97. P. 2983— 2990.Giordano C., Stassi G., De Maria R. et al. Potentional involment of Fas and its ligand in the pathogenesis of Hashimoto’s thyroiditis // Science. 1997. V. 275. P. 960—963.Giordano C., Stassi G., De Maria R. et al. Potentional involment of Fas and its ligand in the pathogenesis of Hashimoto’s thyroiditis // Science. 1997. V. 275. P. 960—963.Griffith T.S., Brunner T., Fletcher S.M. et al. Fas ligand-induced apoptosis as a mechanism of immune privilege // Science. 1995. V. 270. P. 1189—1192.Griffith T.S., Brunner T., Fletcher S.M. et al. Fas ligand-induced apoptosis as a mechanism of immune privilege // Science. 1995. V. 270. P. 1189—1192.Hammond L.J., Lowdell M.W., Cerrano P.G. et al. Analysis of apoptosis in relation to tissue destruction associated with Hashimoto’s autoimmune thyroiditis // J. of Pathology. 1997. V. 182. P. 138—144.Hammond L.J., Lowdell M.W., Cerrano P.G. et al. Analysis of apoptosis in relation to tissue destruction associated with Hashimoto’s autoimmune thyroiditis // J. of Pathology. 1997. V. 182. P. 138—144.Hiromatsu Y., Bednarczuk T., Soyejima E. et al. Increased serum soluble Fas in patients with Graves’ disease // Thyroid. 1999. V. 9. P. 341—345.Hiromatsu Y., Bednarczuk T., Soyejima E. et al. Increased serum soluble Fas in patients with Graves’ disease // Thyroid. 1999. V. 9. P. 341—345.Hiromatsu Y., Hoshino T., Yagita H. et al. Functional Fas ligand expression in thyrocytes from patients with Graves’ disease // J. Clinical Endocrinology and Metabolism. 1999. Vol. 84. P. 2896—2902.Hiromatsu Y., Hoshino T., Yagita H. et al. Functional Fas ligand expression in thyrocytes from patients with Graves’ disease // J. Clinical Endocrinology and Metabolism. 1999. Vol. 84. P. 2896—2902.Ju S.T. et al. Fas (CD95)/FasL interactions required for programmed cell death after activation // Nature. 1995. V. 373. P. 444.Ju S.T. et al. Fas (CD95)/FasL interactions required for programmed cell death after activation // Nature. 1995. V. 373. P. 444.Kalkeri G., Khalap N., Garry R.F. et al. Hepatits С virus protein expression induced apoptosis in HepG2 cells // Virology. 2001. V. 282. 1. P. 26—37. №Kalkeri G., Khalap N., Garry R.F. et al. Hepatits С virus protein expression induced apoptosis in HepG2 cells // Virology. 2001. V. 282. 1. P. 26—37. №Kawakami A., Eguchi K., Matsuoka N. et al. Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro // Endocrinology. 1996. V. 137. P. 3163—3169.Kawakami A., Eguchi K., Matsuoka N. et al. Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro // Endocrinology. 1996. V. 137. P. 3163—3169.Kidd V.J. Proteolytic activities that mediate apoptosis // Annu. Rev. Physiol. 1998. V. 60. P. 533—573.Kidd V.J. Proteolytic activities that mediate apoptosis // Annu. Rev. Physiol. 1998. V. 60. P. 533—573.Krammer P.H. CD95's deadly mission in the immune system // Nature. 2000. V. 407. P. 789—795.Krammer P.H. CD95's deadly mission in the immune system // Nature. 2000. V. 407. P. 789—795.Lenardo M., Chan F.K.-M., Hornug F. et al. Nature T-lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment // Annu. Rev. Immunol. 1999. V. 17. P. 221— 253.Lenardo M., Chan F.K.-M., Hornug F. et al. Nature T-lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment // Annu. Rev. Immunol. 1999. V. 17. P. 221— 253.Lord J.D., McIntoch B.C., Greeberg Ph.D., Nelson B.H. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5 // J. Immynol. 2000. V. 164. P. 2533—2541.Lord J.D., McIntoch B.C., Greeberg Ph.D., Nelson B.H. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5 // J. Immynol. 2000. V. 164. P. 2533—2541.Mei X.W. et al. Induction and detection of apoptosis in human periphery blood T-cells // J. Immunological methods. 1997. V. 206. P. 153 —162.Mei X.W. et al. Induction and detection of apoptosis in human periphery blood T-cells // J. Immunological methods. 1997. V. 206. P. 153 —162.Mitsiades N., Poulaki V., Kotoula V. et al. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto’s thyroiditis // J. Clin. Endocrinology and Metabolism. 1998. V. 83. P. 2199—2203.Mitsiades N., Poulaki V., Kotoula V. et al. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto’s thyroiditis // J. Clin. Endocrinology and Metabolism. 1998. V. 83. P. 2199—2203.Mountz J.D., Wu J., Cheng J., Zhou T. Autoimmune disease: A problem of defective apoptosis // Arthritis Rheum. 1994. V. 37. P. 1415 —1420.Mountz J.D., Wu J., Cheng J., Zhou T. Autoimmune disease: A problem of defective apoptosis // Arthritis Rheum. 1994. V. 37. P. 1415 —1420.Mountz J.D., Zhang H.G., Hsu H.C. et al. Apoptosis and cell death in the endocrine system // Recent Progress in Hormone Research. 1999. V. 54. P. 235—269.Mountz J.D., Zhang H.G., Hsu H.C. et al. Apoptosis and cell death in the endocrine system // Recent Progress in Hormone Research. 1999. V. 54. P. 235—269.Nishimoto I., Okamoto Т., Gramorella U., Iwatsubo T. Apoptosis in neurodegenerative disease // Adv. Pharmacol. 1997. V. 41. P. 337—369.Nishimoto I., Okamoto Т., Gramorella U., Iwatsubo T. Apoptosis in neurodegenerative disease // Adv. Pharmacol. 1997. V. 41. P. 337—369.Pan H., Yin C., Dyke T. Apoptosis and cancer mechanisms // Cancer Surveys. 1997. V. 29. P. 305—327.Pan H., Yin C., Dyke T. Apoptosis and cancer mechanisms // Cancer Surveys. 1997. V. 29. P. 305—327.Palazzo F.F., Ammond L.J., Goode A.W., Mirakian R. Death of the autoimmune thyrocyte: is it pushed or does it jump? // Thyroid. 2000. V. 10. P. 561—572.Palazzo F.F., Ammond L.J., Goode A.W., Mirakian R. Death of the autoimmune thyrocyte: is it pushed or does it jump? // Thyroid. 2000. V. 10. P. 561—572.Paolieri F., Salmaso C., Battifora M. et al. Possible pathogenetic relevance of interleukin-1 beta in «destructive» organ-specific autoimmune disease (Hashimoto's thyroiditis) // Ann. N.Y. Acad. Sci. 1999. V. 22. 876. P. 221—228.Paolieri F., Salmaso C., Battifora M. et al. Possible pathogenetic relevance of interleukin-1 beta in «destructive» organ-specific autoimmune disease (Hashimoto's thyroiditis) // Ann. N.Y. Acad. Sci. 1999. V. 22. 876. P. 221—228.Schober S.L., Kuo C.T., Schluns K.S. et al. Expression of the transcription factor lung Krüppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo // J. Immunol. 1999. V. 163. P. 3662—3667.Schober S.L., Kuo C.T., Schluns K.S. et al. Expression of the transcription factor lung Krüppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo // J. Immunol. 1999. V. 163. P. 3662—3667.Sheikh M.S., Fornace A.J. Death and decoy receptors and p53- mediated apoptosis // Leukemia. 2000. V. 14. P. 1509—1513.Sheikh M.S., Fornace A.J. Death and decoy receptors and p53- mediated apoptosis // Leukemia. 2000. V. 14. P. 1509—1513.Stassi G., Di Liberto D., Todaro M. et al. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins // Nat. Immunol. 2000. V. 1. P. 483—488.Stassi G., Di Liberto D., Todaro M. et al. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins // Nat. Immunol. 2000. V. 1. P. 483—488.Tanaka M., Suda Т., Haze K. et al. Fas ligand in human serum // Nat. Med. 1996. V. 2. P. 317.Tanaka M., Suda Т., Haze K. et al. Fas ligand in human serum // Nat. Med. 1996. V. 2. P. 317.Tanimoto C., Hirakawa S., Kawasaki H. et al. Apoptosis in thyroid diseases: a histochemical study // Endocrine Journal. 1995. V. 42. P. 193—201.Tanimoto C., Hirakawa S., Kawasaki H. et al. Apoptosis in thyroid diseases: a histochemical study // Endocrine Journal. 1995. V. 42. P. 193—201.Weetman A.P., McGregor A.M. Autoimmune thyroid disease: further developments in our understanding // Endocrine Reviews. 1994. V. 15. P. 788—830.Weetman A.P., McGregor A.M. Autoimmune thyroid disease: further developments in our understanding // Endocrine Reviews. 1994. V. 15. P. 788—830.Weetman A.P., McGregor A.M. Antigen presentation in the pathogenesis of autoimmune endocrine disease // J. Autoimmun. 1995. V. 3. P. 305—312.Weetman A.P., McGregor A.M. Antigen presentation in the pathogenesis of autoimmune endocrine disease // J. Autoimmun. 1995. V. 3. P. 305—312.Weetman A.P. Graves' disease // N. Engl. J. Med. 2000. V. 343. P. 1236—1248.Weetman A.P. Graves' disease // N. Engl. J. Med. 2000. V. 343. P. 1236—1248.Yanagisawa J., Takahashi M., Kanki H. et al. The molecular interaction of Fas and FAP-1: a tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis // J. Biol. Chem. 1997. V. 272. P. 8539—8545.Yanagisawa J., Takahashi M., Kanki H. et al. The molecular interaction of Fas and FAP-1: a tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis // J. Biol. Chem. 1997. V. 272. P. 8539—8545.

The authors declare that there are no conflicts of interest present.